Clinical Trial

MDMA Therapy in Veterans With PTSD

Name: MDMA Therapy in Veterans With PTSD — clinical trial record (NCT07569159)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase 2, single-center, fixed-dose, open-label study will explore the efficacy, safety, and tolerability of a 120 mg dose of oral MDMA followed by a supplemental dose of 60 mg MDMA in conjunction with therapy in individual versus group settings for adult veterans diagnosed with PTSD.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-02

Trial Details

NCT Number	NCT07569159
Lead Sponsor	Sunstone Medical
Conditions	Post Traumatic Stress Disorder
Enrollment	52 participants
Start Date	2026-06-30
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-01